{"id":339005,"date":"2026-11-04T13:43:23","date_gmt":"2026-11-04T08:13:23","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-pat-313-crore\/"},"modified":"2026-11-04T13:43:23","modified_gmt":"2026-11-04T08:13:23","slug":"pfizer-q2-results-fy27-pat-313-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-pat-313-crore\/","title":{"rendered":"Pfizer Q2 Results FY27: PAT Jumps 65.72% to Rs 313.25 Cr, Revenue Rs 726.86 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Pfizer Q2 Results FY27 were declared on 3 November 2026 on a standalone basis. Revenue came in at Rs 726.86 Cr, a YoY growth of 13.16 percent from Rs 642.34 Cr. Net profit rose 65.72 percent to Rs 313.25 Cr from Rs 189.02 Cr. These quarterly results cover July to September 2026.<\/p>\n<\/div>\n

Pfizer Ltd (PFIZER) Q2 Results FY27 announced on 3 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 726.86 Cr and PAT of Rs 313.25 Cr. Pfizer Q2 Results FY27 set out the full picture for the quarter. The results date of 3 November 2026 and the standalone results basis frame every figure below.<\/p>\n

This Pfizer Q2 Results results analysis covers the financial highlights, the business factors, the outlook and the risks, and it starts with the Financial Highlights table. Univest readers can use the Univest Screener to compare these figures with other listed companies.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n